LONDON (Reuters) – An experimental vaccine developed by AstraZeneca and the University of Oxford against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hope that it could be in use by the end of the year. Called AZD1222, the vaccine has been …
Read More »The first human trial of the Oxford COVID-19 vaccine is promising
LONDON (Reuters) – An experimental coronavirus vaccine developed by AstraZeneca and the University of Oxford was safe and produced an immune response in early-stage clinical trials, the data showed on Monday, keeping alive the hope that it might be in use. for the end of the year . FILE PHOTO: …
Read More »Synairgen’s actions skyrocket when the drug shows a lower risk of serious cases of COVID-19
(Reuters) – Synairgen Plc (SYNG.L) said Monday that his drug helped reduce the risk of serious cases in hospitalized patients with COVID-19, according to data from a trial of more than 100 people in the UK, which triggered his actions. The trial, which used interferon beta, showed that patients who …
Read More »Florida coronavirus cases surge for fifth day as Trump promises outbreak to be under control
(Reuters) – Florida on Sunday reported more than 12,000 new cases of COVID-19, the fifth day in a row that the state has announced more than 10,000 new infections, even as President Donald Trump promised that “it will be under control.” The virus has claimed more than 140,000 lives in …
Read More »North Korean Kim fires officials for extortion linked to hospital project
SEOUL (Reuters) – The North Korean leader fired officials building a hospital after pressuring the public for contributions, the media reported Monday, the second reprimand linked to the high-profile project in a country rarely they advertise such problems. FILE PHOTO: North Korean leader Kim Jong Un guides the 14th expanded …
Read More »